Benzopyran compounds with anti-complement activity and application of benzopyran compounds
A technology of benzopyran and compounds, applied in the field of benzopyran compounds, to achieve the effect of broad market prospects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0030]
[0031] The monomer compounds, i.e. compound 1 and compound 2, were isolated according to the following steps:
[0032] (1) Soak 17.0kg dry rhododendron leaves with 95% ethanol, extract at room temperature 3 times, each time for 7 days, to obtain 3.8kg ethanol extract;
[0033] (2) The Rhododendron 95% ethanol extract obtained in step (1) is suspended with distilled water, and extracted 3 times with sherwood oil, ethyl acetate, and n-butanol successively to obtain 915 g of sherwood oil extract, ethyl acetate Ester extract 569.0g, n-butanol extract 597g;
[0034] (3) Take 569.0 g of the ethyl acetate extract obtained in step (2), put it in a normal phase silica gel column, and mix it with dichloromethane-methanol (25:1, 20:1, 15:1, 10:1, 5 :1) The solvent system is subjected to gradient elution, and a total of 11 components (Fr.E1-E11) are obtained;
[0035] (4) Take Fr.E1 (154.0g) and install it in a normal phase silica gel column, and perform gradient elution wit...
Embodiment 2
[0040] Example 2. Anti-complement classical pathway test in vitro
[0041] Compound 1 and Compound 2 act on the classical pathway of complement (the classical pathway) to evaluate the anti-complement activity of the compound, and the specific steps are as follows:
[0042] By adding sheep red blood cells (2.0×10 9 individual / mL) and hemolysin (Hemolysin 1:30) (Nanjing Senbega Biotechnology Co., Ltd., item number: SBJ-RXS10) in GVB-Ca 2+ / Mg 2+ (Beijing Kulaibo Technology Co., Ltd., article number: DZSL0356-500ML) to prepare sensitized red blood cells (Eshe), the cell concentration of sensitized Eshe is 1.0×10 9 individual / mL. Dissolve the test sample (compound 1 or compound 2) in DMSO, glucose (negative control) and heparin (positive control) in GVB-Ca 2+ / Mg 2+ middle. A pool of normal human serum (NHSP 1:40) was chosen for maximal lysis in the absence of complement inhibitors. Various dilutions of the test samples were pre-incubated with 150 μL of NHSP for 90 min at 3...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com